News

Avella Newsroom

January 1, 1970|
Avella Selected by Array BioPharma Inc. to Distribute BRAFTOVI (encorafenib) and MEKTOVI (binimetinib)
June 27, 2018| CATEGORIES: Oncology , Cancer , Press Release

The specialty pharmacy will give patients access to this important new FDA-approved combination therapy for patients with advanced BRAF melanoma.

Phoenix, AZ -- Avella has announced that it will distribute BRAFTOVI™ (encorafenib) and MEKTOVI® (binimetinib), a combination therapy recently FDA approved for patients for the treatment of patients with unresectable or metastatic melanoma with a BRAFV600E or BRAFV600K mutation, as detected by an FDA-approved test. 

Specialty Pharmacies Transforming Cancer Care
February 21, 2017| CATEGORIES: Specialty Pharmacy , Cancer , Oncology , Press Mention
As the model of collaborative healthcare expands and grows, every person who participates in patient care will have a distinct role to play to improve patient outcomes. Specialty pharmacies are increasingly bearing the charge of dispensing, distribution reimbursement, case management, and other services that serve a patient’s specific disease needs.

From adherence management to communicating with physicians, coordinating financial assistance, and managing prior authorization, specialty pharmacies offer patients a variety of comprehensive services. At the Patient-Centered Oncology Care® meeting, held November 17-18, 2016, in Baltimore, J. Ike Nicoll, President, The Morrison Group, and Joshua A. Rademacher, MBA, executive vice president, Enterprise Solutions and Business Development, at Avella Specialty Pharmacy, spoke to pairing novel cancer treatments with high-touch and high-technology support. 
News Alerts
If you would like to receive email updates from Avella Specialty Pharmacy, please complete the information below.
Subscribe
Featured Video
Photo of Brian Halligan
Path of a Specialty Prescription
The path of a specialty prescription is complex. This video details each step of the path and the unique offerings of Avella.
Media Contact

Sarah McLeod
800-516-2881  x103
smcleod@activate-health.com

Avella is available to coordinate subject matter expert interviews on a variety of topics including.

  • Specialty pharmacy/pharmacist role
  • Medication adherence and technology
  • Specialty pharmacy pricing considerations

Please contact Sarah McLeod for more information about Avella Specialty Pharmacy.

News Alerts
If you would like to receive email updates from Avella Specialty Pharmacy, please complete the information below.
Subscribe